Calls
1
u/quota_flash
Reddit r/pennystocks
Win Rate
0.0%
return
-76.2%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 13
$14.10
-76.2%
The author claims Utah's approval of AI prescription drugs aligns with Shuttle Pharmaceuticals' recently acquired molecule.ai, positioning the technology as an essential tool for modern drug discovery. The causal mechanism is that the regulatory change makes AI-driven drug discovery state-approved, driving demand for molecule.ai's platform. The catalyst is the Utah regulatory approval, with no explicit time horizon given. No specific risk is stated by the author.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
u/quota_flash has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: SHPH.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
